Researchers have engineered a dual‑stimuli‑responsive nanoparticle that activates the STING pathway only when both acidic pH and hypoxic NQO1 activity are present, creating an AND‑logic release of the agonist MSA‑2. In preclinical models of lung carcinoma, triple‑negative breast cancer and melanoma, the lead formulation (PHM NP) dramatically lowered metastatic nodules while sparing healthy tissue, with toxicity markers comparable to untreated controls. Pharmacokinetic studies showed preferential accumulation in splenic antigen‑presenting cells, driving CD8⁺ T‑cell priming and requiring cDC1 and STING signaling for efficacy. Combination with anti‑PD‑1 further prolonged survival in melanoma, highlighting translational potential.
stated as a critique but what does this mean as no drug has been demonstrated to have anti-aging effects in human clinical trials NR is active versus inflammaging and PAD, which is an age-related conditions affecting 10s of millions of americans you...

The FDA has issued a final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product.” The document outlines the agency’s scientific framework for establishing biosimilarity of therapeutic proteins submitted via the abbreviated licensure pathway. It details expectations for...

I teach future physicians this uncomfortable truth: "aging" is not just time—it's biology we can potentially reprogram. NIH highlights a PNAS study where researchers screened 200 transcription factors to "reset" old human fibroblasts toward a younger gene-expression pattern. They narrowed it to...
Researchers at Uppsala University reported that a single 30 mg/kg injection of the psychedelic N,N‑dimethyltryptamine (DMT) reversed depression‑like behaviors in mice subjected to chronic stress. The treated animals recovered their preference for sweetened water, displayed improved working‑memory performance, and showed reduced...

The newsletter urges donations to support a lab studying lethal childhood glioma, noting NIH grant success rates of only 4‑5%. It reports FDA biologics chief Vinay Prasad’s second departure, a rare leadership turnover that could affect approval stability. Additional highlights...
As a medical school professor, I've watched patients take vitamin D for years with zero improvement in their blood levels. Now a Vanderbilt clinical trial explains why: they're missing magnesium. Key findings: > Magnesium RAISED vitamin D in people who were deficient > But...
Too funny. @emilyakopp (below) outs Vinay Prasad as the host of Thursday’s HHS/FDA media call to discuss $QURE.
A study by Ma and Kim in Nature Communications unveils the dilution‑and‑delay (DnD) susceptibility assay, a high‑resolution, high‑throughput method that combines antibiotic dilution gradients with timed incubation delays. Leveraging microfluidic chips and real‑time imaging, the assay can screen thousands of...

Osteoarthritis & back pain affects millions of people. Instead of managing symptoms, imagine rebuilding joints by making them young New study shows the reprogramming gene combo OSK regrows joints in mice & effect depends on TET2 so it's epigenetic...🧵 https://t.co/AlOIwcEXEQ
DNA breaks are a potent accelerator of epigenetic drift, which some researchers think drives aging. Great work by the Gorbunova lab 👏

Puratos and California Cultured announced a partnership to develop commercially viable lab‑grown cocoa, aiming for a market‑ready product by the end of 2026. The process cultivates cocoa cells from elite flavor samples, shrinking growth time to days once scale is...

Microbiome depletion rejuvenates the aging brain 👉"We confirmed that antibiotic treatment improves vascular density, promotes myelination, enhances neurogenesis, and reduces microglial reactivity. Functionally, microbiome-depleted mice showed improved hippocampal memory performance." https://t.co/XYuJ2kPVbi
Today in #postdigital technology: Australia-based @CorticalLabs’ bio-computer with 200,000 human neuron cells basically “learned” how to play Doom. https://t.co/Uq2JKzG04z

Researchers led by Dr. James Murrough and Dr. Emma Guttman‑Yassky identified the Th2 immune pathway as a contributor to major depressive disorder. Using proteomic profiling and computer modeling, they repurposed dupilumab—an IL‑4 receptor antibody approved for eczema—to target this pathway....

Integration of imaging-based and sequencing-based spatial omics mapping on the same tissue section via DBiTplus https://t.co/YtsDFQNt9H https://t.co/ffKPWLDViY
Lifestyle factors and DNA methylation-based aging clocks: cross-sectional and longitudinal associations in the Singapore diet and healthy aging cohort https://t.co/x0zpRxwOXX
Researchers Forster, Novelli, and Welch applied four frequentist and two Bayesian sequential designs to the COVID‑disrupted UK DISC clinical trial. All six approaches confirmed the trial’s original finding of treatment superiority but suggested different optimal points for restarting patient recruitment....
Molecular and phenotypic blueprint of human hematopoiesis links proliferation stress to stem cell aging https://t.co/3mjdKHKcPc
On Prasad’s last few weeks as CBER chief: 1. It was absurdly inappropriate to bring a large group of reporters together and rail on a pending application “on background” 2. The walk back of the Moderna RTF was a bad...
A team at Gladstone Institutes and the San Francisco VA has launched HIV‑seq, a virus‑specific single‑cell RNA‑sequencing platform that isolates active HIV reservoir cells from patients on antiretroviral therapy (ART). The method captured 25 treated‑patient cells and over 1,000 cells from...
Researchers combined network toxicology, machine‑learning models and SHAP interpretability to show that exposure to the plasticizer Di(2‑ethylhexyl) phthalate (DEHP) generates immune signatures overlapping with Sjögren’s syndrome. By mapping thousands of DEHP‑associated genes, proteins and metabolites, they identified shared pathways involving...

Not many are aware but Japan 🇯🇵 is a true powerhouse when it comes to Stem Cells research & the field of regenerative medicine since 2006 - when stem-cell biologist Shinya Yamanaka, working at Japan’s @KyotoU_News identified a handful of...
GLP-1s already have market cap close to 1/3 of the top 10 biopharma companies combined. Consumer health biotech products will dwarf disease-focused biotech products.
Governments in the UK, US and EU are committing to phase out animal testing, starting with skin‑irritation assays and targeting broader reductions by 2030. Rapid advances in new‑approach methodologies—organs‑on‑chips, organoids and AI‑driven computational models—have driven a fourfold rise in NAM‑only...
Patent Fights, GLP-1 Turf Wars, and the FDA Tightens the Screws | Ep. 952 https://t.co/v0fulR3NfB https://t.co/9gGdkAVvlv
Consumer biotech is perpetually slept on because it doesnt have the returns of pharma. Thats like saying don't build wooden chairs; carpentry is reserved only for yachts. Make. Good. Products. People. Want.
Researchers have identified lysophosphatidylcholine acyltransferase 1 (LPCAT1) as a driver of head and neck squamous cell carcinoma (HNSCC) by amplifying mitochondrial oxidative phosphorylation through the COX17 chaperone. Overexpression of LPCAT1 reshapes mitochondrial membrane lipids, stabilizing COX17 and boosting cytochrome c oxidase activity,...
One of the most impressive advances we've ever seen for some autoimmune diseases: cures https://t.co/OZDuq4Iooy

Fragmentomic liquid biopsy enables early breast cancer detection, molecular subtyping and lymph node assessment https://t.co/RC5rTrFO4l https://t.co/s0Z6lc7Jeb

A recent preclinical study shows that inhibiting interleukin‑2‑inducible T‑cell kinase (ITK) markedly improves the efficacy of anti‑CD19 CAR‑T cells. Researchers combined an ITK‑selective inhibitor with a second‑generation CD19‑CAR construct, observing enhanced cytotoxicity, reduced exhaustion markers, and prolonged persistence in mouse...
Even with AlphaFold, protein structure is not a solved problem. And protein structure was never the bottleneck for drug development anyway. Let me explain.
Bitter Compounds as Multifunctional Agents against Diabetes-associated Cognitive Dysfunction: Bridging Metabolic Regulation and Neuroprotection https://t.co/Xv3xItlP20
Resistant hypertension affects up to 20 % of hypertensive patients and carries heightened cardiovascular risk. Recent phase‑3 studies of aldosterone synthase inhibitors such as baxdrostat and lorundrostat have demonstrated significant ambulatory blood‑pressure reductions, positioning them as potential fourth‑line agents beyond traditional...

Baylor did some new pics photos by my friend Agapito Sanchez Jr. Gosh I’m old, estoy viejo, but still making new vaccines, hope to have results of our hookworm anemia vaccine soon, hoping to reproduce our low cost Covid vaccine...
that’s a high level question MO the specific value of NR relates to the tissue distribution of NMRK1 and NMRK2 NR kinase 2 is strongly upregulated in conditions of NAD decline including heart failure and peripheral neurodegeneration
Vinay Prasad, the FDA’s controversial biologics chief, has announced his departure, marking his second exit within a year. His resignation follows a public dispute over the agency’s handling of rare disease drug approvals, intensifying scrutiny of FDA decision‑making. Critics are...

A mouse study found that a high‑fat, low‑carb ketogenic diet normalized blood‑sugar levels in hyperglycemic mice and, when combined with aerobic training, restored their peak oxygen consumption (VO2max). The diet shifted metabolism toward fatty‑acid oxidation and ketone utilization, eliminating muscle‑remodeling...

A quick search on eBay reveals a flood of Russian‑origin peptide products, from injectable ampoules to dubious oral supplements. The items, marketed by Vita Stream Inc. – a firm linked to former footballer Roman Eremenko – claim bioregulation benefits but...
Human Growth Hormone May Be Detrimental When Used to Accelerate Recovery from Acute Tendon-Bone Interface Injuries https://t.co/L4EOFMKjys
Assuming this is real it may have something to do with their “must pay by Venmo to the following name” (at least that’s how it used to be). FDA is easing up on some aspects of peptides but gray market...
Recent open‑access review maps the human virome’s role in aging, highlighting how gut and circulating viruses influence immunity, inflammation, and metabolism. Age‑related virome changes include expansion of bacteriophage families, reactivation of latent herpesviruses, and altered viral diversity, with centenarians displaying...

Targeting aging hallmarks in brain health within the framework of preventive medicine: mechanistic insights into naringenin's role in longevity, synaptic function, and cellular homeostasis https://t.co/JPiEz5VnQe https://t.co/C0EYPRepwy

PEP protects against age-related inflammation, puts the brake on the aging process in mice, high levels in humans correlate with low inflammation So what is PEP, you ask? phosphoenolpyruvate, from glucose metabolism, a, master regulator, blocks cGAS-STING https://t.co/glMvaHSjOq https://t.co/MSVMBJbHm4
Peptide therapies have moved from niche compounding to mainstream outpatient care, driven by telehealth platforms and rapid market growth. This expansion has attracted regulatory attention, with state boards and courts increasingly referencing USP and as compliance benchmarks. Non‑sterile peptide...
Retrotransposon Activation in the Aged and Alzheimer’s Disease Brain Examined by Nanopore Long-read DNA Sequencing "...we report somatic retrotransposition events in the aging and demented brain..." https://t.co/zkRCMO1Plh
ppl have been asking for head to head comparisons of NR v NMN in humans the data show that at 1.2 g/day, NR had 2.3x the blood NAD-boosting activity versus NMN the paper and the details in this 🧵 https://t.co/7KuP6LXyia
The team led by Inkyung Jung and Yarui Diao introduced scHiCAR, a trimodal single‑cell technology that simultaneously captures transcriptome, epigenome, and 3D genome architecture. By integrating AI, the method achieves ultra‑high throughput at roughly $0.04 per cell and was used...
In February 2026 the FDA approved a suite of targeted therapies, including the HER2‑mutant NSCLC kinase inhibitor zognertinib and the first all‑oral acalabrutinib‑venetoclax combo for CLL/SLL, as well as a BRAF‑targeted encorafenib regimen for metastatic colorectal cancer. A portable tumor‑treating‑fields...

A first‑in‑human phase 1 trial at UC Davis evaluated placental mesenchymal stem cells delivered intra‑uterinely to fetuses with myelomeningocele. Six pregnancies treated between June 2021 and December 2022 resulted in intact repair sites, no cerebrospinal fluid leaks, infections, or tumor formation, and MRI scans...